Elicio Therapeutics, Inc. (ELTX) (CIK 0001601485) CORRESP

Elicio Therapeutics, Inc. (ELTX) (CIK 0001601485) → SEC staff · filed 2025-12-01 · ticker ELTX · SIC 2834 · view PDF on sec.gov ↗
A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

Key facts

Accession number
0001601485-25-000128
Form
CORRESP
Filer
Elicio Therapeutics, Inc. (ELTX) (CIK 0001601485)
CIK
0001601485
Ticker
ELTX
Filed
2025-12-01
SIC industry
2834
HQ
Boston, MA

Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/1601485/000160148525000128/filename1.htm

EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗